Physical Functioning in Heart Failure With Preserved Ejection Fraction

被引:4
作者
Cosiano, Michael F. [1 ]
Tobin, Rachel [1 ]
Mentz, Robert J. [2 ,3 ]
Greene, Stephen J. [2 ,3 ]
机构
[1] Duke Univ, Sch Med, Dept Internal Med, Durham, NC USA
[2] Duke Univ, Div Cardiol, Sch Med, Durham, NC USA
[3] Duke Clin Res Inst, 200 Morris St, Durham, NC 27701 USA
关键词
Physical functioning; HFpEF; quality of life; QUALITY-OF-LIFE; CITY CARDIOMYOPATHY QUESTIONNAIRE; LOWER-EXTREMITY FUNCTION; EXERCISE CAPACITY; SYSTOLIC FUNCTION; ELDERLY-PATIENTS; OLDER PATIENTS; GAIT SPEED; WALK TEST; PERFORMANCE-MEASURES;
D O I
10.1016/j.cardfail.2021.04.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure with preserved ejection fraction (HFpEF) is increasingly prevalent, yet interventions and therapies to improve outcomes remain limited. There has been increasing attention towards the impact of comorbidities and physical functioning (PF) on poor clinical outcomes within this population. In this review, we summarize and discuss the literature on PF in HFpEF, its association with clinical and patient- centered outcomes, and future advances in the care of HFpEF with respect to PF. Multiple PF metrics have been demonstrated to provide prognostic value within HFpEF, yet the data are less robust compared with other patient populations, highlighting the need for further investigation. The evaluation and detection of poor PF provides a potential strategy to improve care in HFpEF, and future studies are needed to under- stand if modulating PF improves clinical and/or patient-reported outcomes. Lay Summary: Patients with heart failure with preserved ejection fraction (HFpEF) commonly have impaired physical functioning (PF) demonstrated by limitations across a wide range of common PF metrics. Impaired PF metrics demonstrate prognostic value for both clinical and patient-reported outcomes in HFpEF, making them plausible therapeutic targets to improve outcomes. Clinical trials are ongoing to investigate novel methods of detecting, monitoring, and improving impaired PF to enhance HFpEF care. Heart failure with preserved ejection fraction (HFpEF) is increasingly prevalent, yet interventions and therapies to improve outcomes remain limited. As such, there has been increasing focus on the impact of physical performance (PF) on clinical and patient-centered outcomes. In this review, we discuss the state of PF in patients with HFpEF by examining the multitude of PF metrics available, their respective strengths and limitations, and their associations with outcomes in HFpEF. We highlight future advances in the care of HFpEF with respect to PF, particularly regarding the evaluation and detection of poor PF.
引用
收藏
页码:1002 / 1016
页数:15
相关论文
共 128 条
  • [21] Quality of life and outcomes in heart failure patients with ejection fractions in different ranges
    Chen, Xin
    Xin, Yanguo
    Hu, Wenyu
    Zhao, Yinan
    Zhang, Zixin
    Zhou, Yinpin
    [J]. PLOS ONE, 2019, 14 (06):
  • [22] Lower Extremity Performance Measures Predict Long-Term Prognosis in Older Patients Hospitalized for Heart Failure
    Chiarantini, Daniela
    Volpato, Stefano
    Sioulis, Fotini
    Bartalucci, Francesca
    Del Bianco, Laura
    Mangani, Irene
    Pepe, Giuseppe
    Tarantini, Francesca
    Berni, Andrea
    Marchionni, Niccolo
    Di Bari, Mauro
    [J]. JOURNAL OF CARDIAC FAILURE, 2010, 16 (05) : 390 - 395
  • [23] Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry
    Chioncel, Ovidiu
    Lainscak, Mitja
    Seferovic, Petar M.
    Anker, Stefan D.
    Crespo-Leiro, Maria G.
    Harjola, Veli-Pekka
    Parissis, John
    Laroche, Cecile
    Piepoli, Massimo Francesco
    Fonseca, Candida
    Mebazaa, Alexandre
    Lund, Lars
    Ambrosio, Giuseppe A.
    Coats, Andrew J.
    Ferrari, Roberto
    Ruschitzka, Frank
    Maggioni, Aldo P.
    Filippatos, Gerasimos
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (12) : 1574 - 1585
  • [24] Objectively measured physical capability levels and mortality: systematic review and meta-analysis
    Cooper, Rachel
    Kuh, Diana
    Hardy, Rebecca
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 : 639
  • [25] Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction
    Dalos, Daniel
    Mascherbauer, Julia
    Zotter-Tufaro, Caroline
    Duca, Franz
    Kammerlander, Andreas A.
    Aschauer, Stefan
    Bonderman, Diana
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (02) : 189 - 199
  • [26] The Future of Wearables in Heart Failure Patients
    DeVore, Adam D.
    Wosik, Jedrek
    Hernandez, Adrian F.
    [J]. JACC-HEART FAILURE, 2019, 7 (11) : 922 - 932
  • [27] Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction The Role of Abnormal Peripheral Oxygen Extraction
    Dhakal, Bishnu P.
    Malhotra, Rajeev
    Murphy, Ryan M.
    Pappagianopoulos, Paul P.
    Baggish, Aaron L.
    Weiner, Rory B.
    Houstis, Nicholas E.
    Eisman, Aaron S.
    Hough, Stacyann S.
    Lewis, Gregory D.
    [J]. CIRCULATION-HEART FAILURE, 2015, 8 (02) : 286 - +
  • [28] Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction The Aldo-DHF Randomized Controlled Trial
    Edelmann, Frank
    Wachter, Rolf
    Schmidt, Albrecht G.
    Kraigher-Krainer, Elisabeth
    Colantonio, Caterina
    Kamke, Wolfram
    Duvinage, Andre
    Stahrenberg, Raoul
    Durstewitz, Kathleen
    Loeffler, Markus
    Duengen, Hans-Dirk
    Tschoepe, Carsten
    Herrmann-Lingen, Christoph
    Halle, Martin
    Hasenfuss, Gerd
    Gelbrich, Goetz
    Pieske, Burkert
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08): : 781 - 791
  • [29] Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction
    Edelmann, Frank
    Stahrenberg, Raoul
    Gelbrich, Goetz
    Durstewitz, Kathleen
    Angermann, Christiane E.
    Duengen, Hans-Dirk
    Scheffold, Thomas
    Zugck, Christian
    Maisch, Bernhard
    Regitz-Zagrosek, Vera
    Hasenfuss, Gerd
    Pieske, Burkert M.
    Wachter, Rolf
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2011, 100 (09) : 755 - 764
  • [30] Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: systematic review and harmonised meta-analysis
    Ekelund, Ulf
    Tarp, Jakob
    Steene-Johannessen, Jostein
    Hansen, Bjorge H.
    Jefferis, Barbara
    Fagerland, Morten W.
    Whincup, Peter
    Diaz, Keith M.
    Hooker, Steven P.
    Chernofsky, Ariel
    Larson, Martin G.
    Spartano, Nicole
    Vasan, Ramachandran S.
    Dohrn, Ing-Mari
    Hagstromer, Maria
    Edwardson, Charlotte
    Yates, Thomas
    Shiroma, Eric
    Anderssen, Sigmund A.
    Lee, I-Min
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2019, 366